Cargando…
Cognitive Impairment and Risk Factors in Post-COVID-19 Hospitalized Patients
INTRODUCTION: Numerous reports regarding cognitive deficits after the coronavirus disease 2019 (COVID-19), described as “brain fog,” have been published. However, the clinical presentations and risk factors of post-COVID-19 cognitive impairment are controversial. This study aimed to assess (a) the p...
Autores principales: | Khieukhajee, Jedsada, Rojana-udomsart, Arada, Srisarakorn, Pinnakarn, Wongsurit, Tanaphon, Aungsumart, Saharat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601842/ https://www.ncbi.nlm.nih.gov/pubmed/37900719 http://dx.doi.org/10.1159/000531743 |
Ejemplares similares
-
Efficacy and safety of monoclonal antibody therapy in patients with neuromyelitis optica spectrum disorder: A systematic review and network meta-analysis
por: Aungsumart, Saharat, et al.
Publicado: (2023) -
Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis
por: Aungsumart, Saharat, et al.
Publicado: (2020) -
Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy
por: Ramanathan, Sudarshini, et al.
Publicado: (2015) -
Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
por: Aungsumart, Saharat, et al.
Publicado: (2023) -
Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations
por: Apiwattanakul, Metha, et al.
Publicado: (2022)